- Home
- FCAP vs CNTB Comparison
FCAP vs CNTB Comparison
Compare FCAP & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCAP | CNTB |
|---|---|---|
| Founded | 1891 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.9M | 128.6M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FCAP | CNTB |
|---|---|---|
| Price | $59.87 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 24.3K | ★ 159.8K |
| Earning Date | 01-23-2026 | 02-14-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ 25.19 | N/A |
| EPS | ★ 4.41 | N/A |
| Revenue | ★ $47,323,000.00 | $762,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24,739.01 |
| P/E Ratio | $13.81 | ★ N/A |
| Revenue Growth | ★ 15.22 | N/A |
| 52 Week Low | $30.49 | $0.51 |
| 52 Week High | $71.00 | $3.28 |
Technical Indicators
Market Signals| Indicator | FCAP | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 58.83 |
| Support Level | $60.32 | $2.11 |
| Resistance Level | $71.00 | $2.65 |
| Average True Range (ATR) | 3.94 | 0.22 |
| MACD | -0.51 | 0.01 |
| Stochastic Oscillator | 50.75 | 77.43 |
Price Performance
Historical ComparisonAbout FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.